|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Erma
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Erma D.O.O. Beograd Headquarters Autoput za Novi Sad 96; Belgrade; Belgrade; 11080 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational YU-MB: 17416626 Financial Auditors: KPMG (2010) Incorporation Date: September 30, 2002 Total Employees: 129 Tel: (+381 11) 2259410 |
|
Company Description |
| Serbian company Erma, which was established in 2002, is primarily engaged in wholesaling pharmaceuticals. In 2004 Avantium S.A. Luxembourg became the sole owner of the company and in 2008 it transferred its share to Cyprus-based Ecanto Investments Limited. Erma distributes products of Glaxosmithkline, Novartis, Mercksharp&Dohme, Astrazeneca, Novartis Consumer Healts, Dr Wolf, Janssen-Cilag, Schering AG, Innotech, KRKA, Alkaloid. |
Key Executives |
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| CRD Company Financial Statements | CRD Company Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
3,658,594 |
2,791,902 |
| ||
Current Assets |
X,XXX,XXX |
X,XXX,XXX |
| ||
Total Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
Shareholders Equity |
XXX,XXX |
XXX,XXX |
| ||
Current Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in RSD. | ||
Income Statement
| ||
Total Operating Revenue |
X,XXX,XXX |
X,XXX,XXX |
| ||
Operational Profit (Loss) |
XXX,XXX |
XXX,XXX |
| ||
Net Profit (Loss) |
XX,XXX |
XX,XXX |
| ||
| * All the accounts are in RSD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.X% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
X.X% |
X.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
X.XX% |
X.XX% |
| ||
Return on Capital |
XX.XX% |
XX.XX% |
| ||
Gross Profit Margin |
X.X% |
X.XX% |
| ||
Operating Profit Margin |
X.XX% |
X.XX% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
X.XXx |
X.XXx |
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XX.XXx |
XX.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX,XXX |
XXX,XXX |
| ||
EBITDA |
XXX,XXX |
XXX,XXX |
| ||
Bookvalue (BV) |
XXX,XXX |
XXX,XXX |
| ||
Net Cash |
-X,XXX,XXX |
-X,XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.X% |
| ||
Quick ratio |
XX.XX% |
XX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
X,XXX.X% |
X,XXX.XX% |
| ||
Debt to equity |
X,XXX.XX% |
X,XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
X% |
X.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX.XX% |
XXX.XX% |
| ||
Net Income Trend |
XXX.XX% |
XX.XX% |
| ||
Operating Income Trend |
XX.XX% |
XXX.XX% |
| ||
 |